𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Gender differences in the presentation of subjects with restless legs syndrome

✍ Scribed by Alison J. Bentley; Kevin D. Rosman; Duncan Mitchell

Book ID
116883768
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
88 KB
Volume
7
Category
Article
ISSN
1389-9457

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Gender differences in the association be
Gender differences in the association between antidepressant use and restless legs syndrome
✍ Kristin R. Baughman; Claire C. Bourguet; Scott K. Ober πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 74 KB

## Abstract Contradictory results have been reported for the association between antidepressant use and Restless Legs Syndrome (RLS). Our aim was to clarify the relationship and examine possible gender differences. We interviewed 1,693 veterans receiving primary care from the Cleveland VA Medical C

Randomized polysomnography study of gaba
Randomized polysomnography study of gabapentin enacarbil in subjects with restless legs syndrome
✍ John W. Winkelman; Richard K. Bogan; Markus H. Schmidt; John D. Hudson; Sarah E. πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 289 KB

## Abstract We assessed the efficacy and tolerability of gabapentin enacarbil in the treatment of moderate to severe primary restless legs syndrome and associated sleep disturbance. This was a multicenter, randomized, double‐blind, placebo‐controlled, 2‐period crossover polysomnography study of gab

State of the art in restless legs syndro
State of the art in restless legs syndrome therapy: Practice recommendations for treating restless legs syndrome
✍ Wolfgang H. Oertel; Claudia Trenkwalder; Marco Zucconi; Heike Benes; Diego Garci πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 115 KB πŸ‘ 1 views

Dopaminergic agents are the best-studied agents and are considered first-line treatment of restless legs syndrome (RLS). Extensive data are available for levodopa, pramipexole, and ropinirole, which have approval for the indication RLS, and to a smaller extent for cabergoline, pergolide, and rotigot